We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a draft revision of an April 2011 guidance, the FDA has laid out its current thinking on when the agency may require postmarket studies or clinical trials for approved prescription drugs. Read More
Reckitt Benckiser (RB Group) has agreed to pay $700 million to settle multiple lawsuits filed by states in federal courts over marketing practices for its addiction treatment drug Suboxone (buprenorphine). Read More
The drugmakers are accused of engaging in “contracts, combinations and conspiracies that restrained trade, inflated prices, and reduced competition in the generic pharmaceutical industry.” Read More
Pharma companies that made and marketed Zantac (ranitidine) are facing lawsuits in California, Colorado and Pennsylvania alleging that they failed to disclose or investigate the drug’s dangers. Read More
Humana filed suit against Teva and 30 other generic drugmakers in a Pennsylvania federal court for allegedly conspiring to fix the prices of more than 100 generic drugs. Read More
Connecticut Attorney General William Tong said he is pleased that the company now has less than 30 days to convince the remaining states to accept a settlement. Read More